Overall, the results of the present study are compatible with the postulate that the interaction among NAFLD, Fetuin-A and atherosclerosis probably varies based on the localization of atherosclerosis. The gene discussed is AHSG; the disease is metabolic dysfunction-associated steatotic liver disease.